Home › The Angeles Clinic and Research Institute Releases Interim Data from...
 

Keywords :   


The Angeles Clinic and Research Institute Releases Interim Data from...

2013-06-05 09:48:23| Logistics - Topix.net

The Angeles Clinic and Research Institute has released preliminary results from an ongoing Phase IB expansion study evaluating the safety and efficacy of lambrolizumab , an investigational antibody therapy currently being developed by Merck that targets programmed cell death-1 protein in patients with advanced melanoma.

Tags: from data research angeles

Category:Transportation and Logistics

Latest from this category

All news
17.06Atlantic Tropical Weather Outlook
17.06Eastern North Pacific Tropical Weather Outlook
17.06Atlantic Tropical Weather Outlook
17.06Eastern North Pacific Tropical Weather Outlook
16.06Eastern North Pacific Tropical Weather Outlook
16.06Atlantic Tropical Weather Outlook
16.06Eastern North Pacific Tropical Weather Outlook
16.06Atlantic Tropical Weather Outlook
Transportation and Logistics »
17.06Wrap sold in WH Smith recalled over E. coli fears
17.06Atlantic Tropical Weather Outlook
17.06Eastern North Pacific Tropical Weather Outlook
17.06Pixar's Inside Out 2 sees record opening weekend
17.06Atlantic Tropical Weather Outlook
17.06Eastern North Pacific Tropical Weather Outlook
17.06Too much of a good thing? Spain's green energy can exceed demand
16.06Eastern North Pacific Tropical Weather Outlook
More »